Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles
- Advisory Board: Eli Lilly and Company; NextWave Pharmaceuticals, Inc.; Noven Pharmaceuticals; Sunovion Pharmaceuticals Inc.
- Grant Support: National Institutes of Health
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
- Research Support: Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals); Supernus Pharmaceuticals, Inc.